Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, Noonan D, Salio M, Camussi G, Rockl W, Bussolino F (1996). The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med
2: 1371–1375.
CAS
PubMed
Google Scholar
Alessi DR, Caudwell FB, Andjelkovic M, Hemmings BA, Cohen P (1996). Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett
399: 333–338.
CAS
PubMed
Google Scholar
Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F (1997). HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med
186: 139–146.
CAS
PubMed
Google Scholar
Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, Moser B, Baggiolini M (1996). HIV blocked by chemokine antagonist. Nature
383: 400.
CAS
PubMed
Google Scholar
Barillari G, Gendelman R, Gallo RC, Ensoli B (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A
90: 7941–7945.
CAS
PubMed
Google Scholar
Benelli R, Mortarini R, Anichini A, Giunciuglio D, Noonan DM, Montalti S, Tacchetti C, Albini A (1998). Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides. AIDS
12: 261–268.
CAS
PubMed
Google Scholar
Berger JR, Moskowitz L, Fischl M, Kelley RE (1987). Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J
80: 683–686.
CAS
PubMed
Google Scholar
Bonwetsch R, Croul S, Richardson MW, Lorenzana C, Valle LD, Sverstiuk AE, Amini S, Morgello S, Khalili K, Rappaport J (1999). Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J Neuro Virol
5: 685–694.
CAS
Google Scholar
Borgatti P, Zauli G, Colamussi ML, Gibellini D, Previati M, Cantley LL, Capitani S (1997). Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur J Immunol
27: 2805–2811.
CAS
PubMed
Google Scholar
Bornemann MA, Verhoef J, Peterson PK (1997). Macrophages, cytokines, and HIV. J Lab Clin Med
129: 10–16.
CAS
PubMed
Google Scholar
Bruce-Keller AJ, Barger SW, Moss NI, Pham JT, Keller JN, Nath A (2001). Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. J Neurochem
78: 1315–1324.
CAS
PubMed
Google Scholar
Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D, et al (1991). HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol
1: 143–152.
CAS
PubMed
Google Scholar
Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, Lokensgard JR (2001). Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J NeuroVirol
7: 135–147.
CAS
PubMed
Google Scholar
Chen P, Mayne M, Power C, Nath A (1997). The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem
272: 22385–22388.
CAS
PubMed
Google Scholar
Chirmule N, Than S, Khan SA, Pahwa S (1995). Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol
69: 492–498.
CAS
PubMed
Google Scholar
Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, Transidico P, Vagani A, Sozzani S, Mantovani A, Lazzarin A, Poli G (1998). Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS
12: 1327–1332.
CAS
PubMed
Google Scholar
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science
270: 1811–1815.
CAS
PubMed
Google Scholar
Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A
95: 3117–3121.
CAS
PubMed
Google Scholar
D’Aversa TG, Weidenheim KM, Berman JW (2002). CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol
160: 559–567.
PubMed
Google Scholar
Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, Albini A, Camussi G (2002). HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi’s sarcoma cells. J Biol Chem
277: 25195–25202.
CAS
PubMed
Google Scholar
Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger-Hodges MJ, Volsky DJ (1987). Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol
61: 3774–3782.
CAS
PubMed
Google Scholar
Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF (1991). Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest
64: 135–156.
CAS
PubMed
Google Scholar
Ehrlich LC, Hu S, Sheng WS, Sutton RL, Rockswold GL, Peterson PK, Chao CC (1998). Cytokine regulation of human microglial cell IL-8 production. J Immunol
160: 1944–1948.
CAS
PubMed
Google Scholar
Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol
67: 277–287.
CAS
PubMed
Google Scholar
Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986). Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics
78: 678–687.
CAS
PubMed
Google Scholar
Esser R, Glienke W, von Briesen H, Rubsamen-Waigmann H, Andreesen R (1996). Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood
88: 3474–3481.
CAS
PubMed
Google Scholar
Eugenin EA, D’Aversa TG, Lopez L, Calderon TM, Berman JW (2003). MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem
85: 1299–1311.
CAS
PubMed
Google Scholar
Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE (1998). Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi’s sarcoma cells. J Virol
72: 6131–6137.
CAS
PubMed
Google Scholar
Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A (1999). MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature
398: 718–723.
CAS
PubMed
Google Scholar
Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol
38: 755–762.
CAS
PubMed
Google Scholar
Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993). Clinical-neuropathologic correlation in HIV-associated dementia. Neurology
43: 2230–2237.
CAS
PubMed
Google Scholar
Gordon CJ, Muesing MA, Proudfoot AE, Power CA, Moore JP, Trkola A (1999). Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol
73: 684–694.
CAS
PubMed
Google Scholar
Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med
107: 828–836.
CAS
PubMed
Google Scholar
Gray F, Adle-Biassette H, Brion F, Ereau T, le Maner I, Levy V, Corcket G (2000). Neuronal apoptosis in human immunodeficiency virus infection. J Neuro Virol
6 (Suppl 1): S38-S43.
Google Scholar
Haseltine WA, Wong-Staal F (1988). The molecular biology of the AIDS virus. Sci Am
259: 52–62.
CAS
PubMed
Google Scholar
Helland DE, Welles JL, Caputo A, Haseltine WA (1991). Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol
65: 4547–4549.
CAS
PubMed
Google Scholar
Hemmings BA (1997). Akt signaling: linking membrane events to life and death decisions. Science
275: 628–630.
CAS
PubMed
Google Scholar
Hesselgesser J, Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J NeuroVirol
5: 13–26.
CAS
PubMed
Google Scholar
Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM (1994). Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol
54: 19–28.
CAS
PubMed
Google Scholar
Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998). Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol
44: 831–835.
CAS
PubMed
Google Scholar
Kelly MD, Naif HM, Adams SL, Cunningham AL, Lloyd AR (1998). Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol
160: 3091–3095.
CAS
PubMed
Google Scholar
Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ (2003). Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol
162: 1693–1707.
CAS
PubMed
Google Scholar
Kinter A, Catanzaro A, Monaco J, Ruiz M, Justement J, Moir S, Arthos J, Oliva A, Ehler L, Mizell S, Jackson R, Ostrowski M, Hoxie J, Offord R, Fauci AS (1998). CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc Natl Acad Sci U S A
95: 11880–11885.
CAS
PubMed
Google Scholar
Kolson DL, Lavi E, Gonzalez-Scarano F (1998). The effects of human immunodeficiency virus in the central nervous system. Adv Virus Res
50: 1–47.
CAS
PubMed
Google Scholar
Kruman II, Nath A, Maragos WF, Chan SL, Jones M, Rangnekar VM, Jakel RJ, Mattson MP (1999). Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. Am J Pathol
155: 39–46.
CAS
PubMed
Google Scholar
Kruman II, Nath A, Mattson MP (1998). HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol
154: 276–288.
CAS
PubMed
Google Scholar
Kutsch O, Oh J, Nath A, Benveniste EN (2000). Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol
74: 9214–9221.
CAS
PubMed
Google Scholar
Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S (1996a). HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol
156: 1638–1645.
CAS
PubMed
Google Scholar
Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S (1996b). HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol
157: 974–977.
CAS
PubMed
Google Scholar
Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM (2001). Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol
75: 8195–8202.
CAS
PubMed
Google Scholar
Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K (1989). The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science
243: 1464–1466.
CAS
PubMed
Google Scholar
Lipton SA, Gendelman HE (1995). Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med
332: 934–940.
CAS
PubMed
Google Scholar
Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ (2000). Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med
6: 1380–1387.
CAS
PubMed
Google Scholar
Luo Y, Fischer FR, Hancock WW, Dorf ME (2000). Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J Immunol
165: 4015–4023.
CAS
PubMed
Google Scholar
Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol
71: 2495–2499.
CAS
PubMed
Google Scholar
Marcuzzi A, Weinberger J, Weinberger OK (1992). Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol
66: 4228–4232.
CAS
PubMed
Google Scholar
Marder K, Albert S, Dooneief G, Stern Y, Ramachandran G, Epstein L (1996). Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology
47: 1247–1253.
Google Scholar
Marzolo MP, von Bernhardi R, Bu G, Inestrosa NC (2000). Expressionofalpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J Neurosci Res
60: 401–411.
CAS
PubMed
Google Scholar
Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A (2000). Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry
69: 376–380.
CAS
PubMed
Google Scholar
Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA (1992). Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol
51: 585–593.
CAS
PubMed
Google Scholar
Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol
42: 963–972.
CAS
PubMed
Google Scholar
Matsumoto T, Miike T, Nelson RP, Trudeau WL, Lockey RF, Yodoi J (1993). Elevated serum levels of IL-8 in patients with HIV infection. Clin Exp Immunol
93: 149–151.
CAS
PubMed
Google Scholar
Mayne M, Holden CP, Nath A, Geiger JD (2000). Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol
164: 6538–6542.
CAS
PubMed
Google Scholar
McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP, et al (1993). Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology
43: 2245–2252.
CAS
PubMed
Google Scholar
McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A, Berman JW (2000). Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol
156: 1441–1453.
CAS
PubMed
Google Scholar
Mengozzi M, De Filippi C, Transidico P, Biswas P, Cota M, Ghezzi S, Vicenzi E, Mantovani A, Sozzani S, Poli G (1999). Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood
93: 1851–1857.
CAS
PubMed
Google Scholar
Mitola S, Sozzani S, Luini W, Primo L, Borsatti A, Weich H, Bussolino F (1997). Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood
90: 1365–1372.
CAS
PubMed
Google Scholar
Moestrup SK, Gliemann J, Pallesen G (1992). Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res
269: 375–382.
CAS
PubMed
Google Scholar
Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A (2000). Kaposi’s sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Biochem Biophys Res Commun
273: 267–271.
CAS
PubMed
Google Scholar
Nath A, Hartloper V, Furer M, Fowke KR (1995). Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol
54: 320–330.
CAS
PubMed
Google Scholar
Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000). Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol
47: 186–194.
CAS
PubMed
Google Scholar
Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD (1996). Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol
70: 1475–1480.
CAS
PubMed
Google Scholar
New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA (1998). HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem
273: 17852–17858.
CAS
PubMed
Google Scholar
Nicolini A, Ajmone-Cat MA, Bernardo A, Levi G, Minghetti L (2001). Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem
79: 713–716.
CAS
PubMed
Google Scholar
Polazzi E, Levi G, Minghetti L (1999). Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J Neuropathol Exp Neurol
58: 825–831.
CAS
PubMed
Google Scholar
Prendergast MA, Rogers DT, Mulholland PJ, Littleton JM, Wilkins LH Jr, Self RL, Nath A (2002). Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitivesite on the N-methyl-D-aspartate receptor. Brain Res
954: 300–307.
CAS
PubMed
Google Scholar
Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988). The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science
239: 586–592.
CAS
PubMed
Google Scholar
Rezaie P, Trillo-Pazos G, Greenwood J, Everall IP, Male DK (2002). Motility and ramification of human fetal microglia in culture: an investigation using time-lapse video microscopy and image analysis. Exp Cell Res
274: 68–82.
CAS
PubMed
Google Scholar
Rollins BJ (1997). Chemokines. Blood
90: 909–928.
CAS
PubMed
Google Scholar
Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol
8: 136–142.
PubMed
Google Scholar
Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL (1998). Chemokines and receptors in HIV encephalitis. AIDS
12: 1021–1026.
CAS
PubMed
Google Scholar
Sasseville VG, Smith MM, Mackay CR, Pauley DR, Mansfield KG, Ringler DJ, Lackner AA (1996). Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol
149: 1459–1467.
CAS
PubMed
Google Scholar
Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B (1996). Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A
93: 700–704.
CAS
PubMed
Google Scholar
Schroder JM, Mrowietz U, Morita E, Christophers E (1987). Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol
139: 3474–3483.
CAS
PubMed
Google Scholar
Sheng WS, Hu S, Hegg CC, Thayer SA, Peterson PK (2000). Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin Immunol
96: 243–251.
CAS
PubMed
Google Scholar
Sopper S, Demuth M, Stahl-Hennig C, Hunsmann G, Plesker R, Coulibaly C, Czub S, Ceska M, Koutsilieri E, Riederer P, Brinkmann R, Katz M, ter Meulen V (1996). The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology
220: 320–329.
CAS
PubMed
Google Scholar
Spencer DC, Price RW (1992). Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol
46: 655–693.
CAS
PubMed
Google Scholar
Stoll G, Jander S (1999). The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol
58: 233–247.
CAS
PubMed
Google Scholar
Tarzami ST, Cheng R, Miao W, Kitsis RN, Berman JW (2002). Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J Mol Cell Cardiol
34: 209–221.
CAS
PubMed
Google Scholar
Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ (1993). Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med
177: 1809–1814.
CAS
PubMed
Google Scholar
Thomas CA, Dobkin J, Weinberger OK (1994). TAT-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells. J Immunol
153: 3831–3839.
CAS
PubMed
Google Scholar
Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML, Pargellis CA (1997). A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol
4: 311–316.
CAS
PubMed
Google Scholar
Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP (1996). CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature
384: 184–187.
CAS
PubMed
Google Scholar
Trkola A, Gordon C, Matthews J, Maxwell E, Ketas T, Czaplewski L, Proudfoot AE, Moore JP (1999). The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J Virol
73: 6370–6379.
CAS
PubMed
Google Scholar
Tyor WR, Power C, Gendelman HE, Markham RB (1993). A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci U S A
90: 8658–8662.
CAS
PubMed
Google Scholar
Walz A, Peveri P, Aschauer H, Baggiolini M (1987). Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun
149: 755–761.
CAS
PubMed
Google Scholar
Weeks BS, Lieberman DM, Johnson B, Roque E, Green M, Loewenstein P, Oldfield EH, Kleinman HK (1995). Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49–58 basic domain. J Neurosci Res
42: 34–40.
CAS
PubMed
Google Scholar
Weiss JM, Downie SA, Lyman WD, Berman JW (1998). Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J Immunol
161: 6896–6903.
CAS
PubMed
Google Scholar
Weiss JM, Nath A, Major EO, Berman JW (1999). HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol
163: 2953–2959.
CAS
PubMed
Google Scholar
Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature
375: 497–500.
CAS
PubMed
Google Scholar
Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG (1998). Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol
152: 659–665.
CAS
PubMed
Google Scholar
Wiley CA, Baldwin M, Achim CL (1996). Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS
10: 843–847.
CAS
PubMed
Google Scholar
Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991). Neocortical damage during HIV infection. Ann Neurol
29: 651–657.
CAS
PubMed
Google Scholar
Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A
83: 7089–7093.
CAS
PubMed
Google Scholar
Wolf BB, Lopes MB, VandenBerg SR, Gonias SL (1992). Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol
141: 37–42.
CAS
PubMed
Google Scholar
Xiong H, Boyle J, Winkelbauer M, Gorantla S, Zheng J, Ghorpade A, Persidsky Y, Carlson KA, Gendelman HE (2003). Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J Neurosci Res
71: 600–607.
CAS
PubMed
Google Scholar
Yoshimura T, Robinson EA, Appella E, Matsushima K, Showalter SD, Skeel A, Leonard EJ (1989). Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol Immunol
26: 87–93.
CAS
PubMed
Google Scholar